Living Longer on Ventricular Assist Devices

February 14, 2023


Read time:

<5 mins
Medal 10 Years Patient Staff
Presented by Health Lab

Ventricular assist devices were first approved in 2010 by the FDA as destination therapy for heart failure patients who were not considered candidates for heart transplant surgery. A VAD acts as a pump to help the heart distribute blood throughout the body, and over the years, the evolution of the VAD has led to significant improvements that have allowed heart failure patients to live longer lives.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.